Andere talen Qlucore AB

Aandelen

QCORE

SE0016829824

Beurs gesloten - Nasdaq Stockholm Andere beurzen 18:00:00 26-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
8,95 ^SEK	+2,87%		-0,56%	+16,99%

30/05	Qlucore AB (publ) rapporteert resultaten voor het gehele jaar eindigend op 30 april 2024	CI
29/05	Uppsala University Hospital kiest Qlucore AB (publ) voor de ontwikkeling van precisiediagnostiek	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Qlucore AB Reports Earnings Results for the Full Year Ended April 30, 2024	30/05
Uppsala University Hospital chooses AI-based Qlucore Insights to develop precision diagnostics	29/05
Uppsala University Hospital Chooses Qlucore AB Insights to Develop Precision Diagnostics	29/05
Invitation to presentation including Q&A session of Qlucore’s year end report report for the period 1 May 2023 – 30 April 2024	28/05
Qlucore Initiates Software Development Project for Cancer Diagnostics	27/05
Qlucore starts project after receiving prestigious EU grant to advance personalized cancer treatment	27/05
Qlucore Starts Project After Receiving EU Grant to Advance Personalized Cancer Treatment	27/05
Qlucore releases unique AI-based solution in the field of lung cancer subtyping	22/05
Qlucore AB Releases Unique AI-Based Solution in the Field of Lung Cancer Subtyping	22/05
Rigshospitalet in Denmark implements Qlucore Insights in analysis workflow for leukemia patients	30/04
Qlucore Omics Explorer expands to the cloud - even more flexible data analysis	08/04
Qlucore Announces the Launch of the Qlucore Omics Explorer Cloud Version	08/04
Interim report 1 May 2023 - 31 January 2024	28/02
Qlucore AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	28/02
Grant from EU	27/02
Qlucore AB Announces Grant from EU	27/02
Invitation to presentation including Q&A session of Qlucore’s interim report for the period 1 November 2023 – 31 January 2024	27/02
Qlucore Submits Technical Documentation for CE Marking of Pediatric Leukemia Medical Device	30/01
Qlucore Diagnostics for Pediatric leukemia takes a Significant step closer to CE marking	30/01
Qlucore Diagnostics for Pediatric Leukemia Takes A Significant Step Closer to Ce Marking	30/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Qlucore AB

Aandelen

QCORE

SE0016829824

Andere talen

Filters